Slimming Products - Norway
Slimming products continued to be impacted by the tendency for consumers to strive towards a healthier overall diet and lifestyles, turning away from the occasional use of slimming products for... |
OTC Obesity - Norway
Sales of OTC obesity products reached NOK10 million in 2009 following the introduction of the first clinically-approved product in this category.
Euromonitor International's OTC Obesity Products in Norway report offers a... |
Digestive Remedies in Denmark
Digestive remedies value increased by 1% as DKr351 million sales were recorded in 2010. This was mainly because Danish chemists/pharmacies were offering more generics and parallel imports to provide the... |
Generic Growth Strategies
Manufacturers to Increase Focus on Super Generics and Biosimilars to Drive Revenues
Generic Growth Strategies - Manufacturers to Increase Focus on Super Generics and Biosimilars to Drive Revenues
Summary
GBI Research has released its research "Generic Growth Strategies - Manufacturers to Increase Focus on... |
Consolidation in the Generic Pharmaceutical Industry
An Evolving Landscape
For many years generic companies were the poor relations of the pharmaceutical industry, with modest growth rates and little or no transnational business operations. As generics companies have grown, often... |
King Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare
Deals and Alliances Profile
King Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary
King Pharmaceuticals, Inc. (King) is an integrated pharmaceutical company that develops, manufactures and markets therapies and technologies to the... |
Global Generics
Global generics market was valued at US$106.12 billion in 2008, registering a growth of 12.56% over the previous year, which is five times that of patented drugs. Cygnus estimates that... |
IMS Company Profiles:Actavis
IMS Company Profiles gives a clear picture of the companies' strengths in terms of therapy areas and relevant marketed products as well as the future strategic direction of companies including... |
Growth Strategies for Supergenerics Organizations
Supergenerics companies are focusing on more challenging therapy areas of supergeneric development such as obesity and rheumatoid arthritis/pain which have seen NCEs fail and drug withdrawals over the last few... |
Generic Drugs: The Global Market--Focus on Asia
REPORT HIGHLIGHTS
THIS REPORT CONTAINS
An examination of the strategies employed by companies specializing in generics to meet the challenges of this highly competitive market as well as those utilized by "originator"... |
Wound Treatments in Denmark
Euromonitor International's Wound Treatments in Denmark report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales... |
Generic Drugs: The Global Market--Focus on Europe
REPORT HIGHLIGHTS
THIS REPORT CONTAINS:
An examination of the strategies employed by companies specializing in generics to meet the challenges of this highly competitive market as well as those utilized by "originator"... |
UK Generics Market Analysis
The UK is one of the largest economies in the world. The per capita income and spending has been also increasing for the last few years. Besides, due to the... |
Generic Drugs: The Global Market--Focus on the Americas
REPORT HIGHLIGHTS
THIS REPORT CONTAINS:
An examination of the strategies employed by companies specializing in generics to meet the challenges of this highly competitive market as well as those utilized by "originator"... |
The Indian Pharmaceutical Industry
New strategies in a changing world
The Indian Pharmaceutical Industry: New strategies in a changing world is a new, insightful and data-rich management report packed with facts, maps and statistics. Published in June 2010 and extending... |
UK Generics Drug Market Analysis
The Pharmaceutical market in the UK is one of largest markets in the world in terms of sales. The spending on healthcare in the country has grown significantly over the... |
Global Generics Industry Report
The global generics market has grown at a rate of 20% in 2005; which is four times that of patented drugs and over three times that of pharmaceutical market. ... |
Pharmaceuticals
The global outlook series on Pharmaceuticals provides a collection of statistical anecdotes, market briefs, and concise summaries of research findings. The report provides a bird's eye view of the pharmaceutical... |
Generic Drugs
The Global Market
REPORT HIGHLIGHTS
THIS REPORT CONTAINS:
An examination of the strategies employed by companies specializing in generics to meet the challenges of this highly competitive market as well as those utilized by "originator"... |
